Thus, our observations (Figure S8) employing FD/LC analyses of clinical samples from patients with MT KRAS NSCLC had a higher percentage of FOXP3+ Treg-like cells underscore the significance of the present study. This evidence concerns the gene FOXP3 and non-small cell lung carcinoma.